Professional Documents
Culture Documents
Lehnes Pharmacotherapeutics For Advanced Practice Providers Ebook PDF
Lehnes Pharmacotherapeutics For Advanced Practice Providers Ebook PDF
Types of Seizures
Prescribing and Monitoring Considerations for Drugs Used to Treat Muscle Spasm: Centrally
Acting Skeletal Muscle Relaxants
Opioid Antagonists
Cluster Headaches
Tension-Type Headache
Management of Schizophrenia
Chapter 25 Antidepressants
Major Depression: Clinical Features, Pathogenesis, and Treatment Overview
Peripartum Depression
Mood-Stabilizing Drugs
Antipsychotic Drugs
Benzodiazepine-Like Drugs
Barbiturates
Management of Insomnia
Other Hypnotics
Panic Disorder
Obsessive-Compulsive Disorder
Attention-Deficit/Hyperactivity Disorder
Neurobiology of Addiction
Psychostimulants
Psychedelics
Dextromethorphan
Inhalants
Anabolic Steroids
Unit IX Drugs that Affect the Heart, Blood Vessels, Blood, and
Blood Volume
Chapter 35 Diuretics
Review of Renal Anatomy and Physiology
Introduction to Diuretics
Loop Diuretics
Potassium-Sparing Diuretics
Chapter 36 Drugs Acting on the Renin-Angiotensin-Aldosterone System
Physiology of the Renin-Angiotensin-Aldosterone System
Aldosterone Antagonists
Verapamil and Diltiazem: Agents That Act on Vascular Smooth Muscle and the Heart
Chapter 38 Vasodilators
Basic Concepts in Vasodilator Pharmacology
Plasma Lipoproteins
Organic Nitrates
Beta Blockers
Ranolazine
Treatment Measures
Anticoagulants
Antiplatelet Drugs
Chapter 45 Drugs for Deficiency Anemias
Red Blood Cell Development
Iron Deficiency
Insulin
Thyroid Pathophysiology
Estrogens
Progestins
Oral Contraceptives
Long-Acting Contraceptives
Spermicides
Emergency Contraception
Chapter 50 Androgens
Testosterone
Cell-Mediated Immunity
Target Diseases
Chapter 54 Antihistamines
Histamine
Acetaminophen
Overview of Therapy
Glucocorticoids
Calcium-Related Pathophysiology
Osteoporosis
Antiinflammatory Drugs
Bronchodilators
Glucocorticoid/Long-Acting Beta2 Agonist Combinations
Management of Asthma
Overview of Treatment
Antibacterial Drugs
Chapter 63 Laxatives
General Considerations
Laxative Abuse
Antidiarrheal Agents
Prokinetic Agents
Pancreatic Enzymes
Anorectal Preparations
Chapter 65 Vitamins
Basic Considerations
Fat-Soluble Vitamins
Water-Soluble Vitamins
Weight-Loss Drugs
Selection of Antibiotics
Carbapenems
Macrolides
Trimethoprim
Trimethoprim/Sulfamethoxazole
Drug Interactions
HIV Vaccines
Keeping Current
Gonococcal Infections
Nongonococcal Urethritis
Acute Epididymitis
Syphilis
Bacterial Vaginosis
Trichomoniasis
Chancroid
Proctitis
Venereal Warts
Chapter 81 Anthelmintics
Classification of Parasitic Worms
Helminthic Infestations
Cytotoxic Agents
Management Strategy
Drug Therapy
Nondrug Therapy
Patient Education
Acne
Sunscreens
Local Anesthetics
Gaudron.
FIN
1.D. The copyright laws of the place where you are located also
govern what you can do with this work. Copyright laws in most
countries are in a constant state of change. If you are outside
the United States, check the laws of your country in addition to
the terms of this agreement before downloading, copying,
displaying, performing, distributing or creating derivative works
based on this work or any other Project Gutenberg™ work. The
Foundation makes no representations concerning the copyright
status of any work in any country other than the United States.
1.E.6. You may convert to and distribute this work in any binary,
compressed, marked up, nonproprietary or proprietary form,
including any word processing or hypertext form. However, if
you provide access to or distribute copies of a Project
Gutenberg™ work in a format other than “Plain Vanilla ASCII” or
other format used in the official version posted on the official
Project Gutenberg™ website (www.gutenberg.org), you must, at
no additional cost, fee or expense to the user, provide a copy, a
means of exporting a copy, or a means of obtaining a copy upon
request, of the work in its original “Plain Vanilla ASCII” or other
form. Any alternate format must include the full Project
Gutenberg™ License as specified in paragraph 1.E.1.
• You pay a royalty fee of 20% of the gross profits you derive
from the use of Project Gutenberg™ works calculated using
the method you already use to calculate your applicable
taxes. The fee is owed to the owner of the Project
Gutenberg™ trademark, but he has agreed to donate
royalties under this paragraph to the Project Gutenberg
Literary Archive Foundation. Royalty payments must be paid
within 60 days following each date on which you prepare (or
are legally required to prepare) your periodic tax returns.
Royalty payments should be clearly marked as such and
sent to the Project Gutenberg Literary Archive Foundation at
the address specified in Section 4, “Information about
donations to the Project Gutenberg Literary Archive
Foundation.”
• You comply with all other terms of this agreement for free
distribution of Project Gutenberg™ works.
1.F.
Most people start at our website which has the main PG search
facility: www.gutenberg.org.